Global Autoimmune Disease Diagnostics Market to reach USD 7.5 billion by 2026

Global Autoimmune Disease Diagnostics Market Size study, by Type (Localized Autoimmune Disease Diagnostic, Systemic Autoimmune Disease Diagnostic,), Product (Drugs, Therapeutic & Monitoring Equipment, Diagnostic Equipment), Technology (Bridge Therapy, Disease-Modifying Antirheumatic drugs (DMARD), Topical Therapy, Phototherapy, Helminthic Therapy, Recombinant Technology) and Regional Forecasts 2020-2026
Product Code:  HALMD_54497453
Chapter 1. Executive Summary 
 1.1. Market Snapshot
 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
 1.2.1. Autoimmune Disease Diagnostics Market, by Region, 2018-2026 (USD Billion)
 1.2.2. Autoimmune Disease Diagnostics Market, by Type, 2018-2026 (USD Billion)
 1.2.3. Autoimmune Disease Diagnostics Market, by Product, 2018-2026 (USD Billion)
 1.2.4. Autoimmune Disease Diagnostics Market, by Technology, 2018-2026 (USD Billion)
 1.3. Key Trends
 1.4. Estimation Methodology
 1.5. Research Assumption
 Chapter 2. Global Autoimmune Disease Diagnostics Market Definition and Scope 
 2.1. Objective of the Study
 2.2. Market Definition & Scope
 2.2.1. Scope of the Study
 2.2.2. Industry Evolution
 2.3. Years Considered for the Study
 2.4. Currency Conversion Rates
 Chapter 3. Global Autoimmune Disease Diagnostics Market Dynamics 
 3.1. Autoimmune Disease Diagnostics Market Impact Analysis (2018-2026)
 3.1.1. Market Drivers
 3.1.2. Market Challenges
 3.1.3. Market Opportunities
 Chapter 4. Global Autoimmune Disease Diagnostics Market Industry Analysis
 4.1. Porter’s 5 Force Model
 4.1.1. Bargaining Power of Suppliers
 4.1.2. Bargaining Power of Buyers
 4.1.3. Threat of New Entrants
 4.1.4. Threat of Substitutes
 4.1.5. Competitive Rivalry
 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
 4.2. PEST Analysis
 4.2.1. Political 
 4.2.2. Economical
 4.2.3. Social 
 4.2.4. Technological 
 4.3. Investment Adoption Model
 4.4. Analyst Recommendation & Conclusion
 Chapter 5. Global Autoimmune Disease Diagnostics Market, by Type
 5.1. Market Snapshot 
 5.2. Global Autoimmune Disease Diagnostics Market by Type, Performance - Potential Analysis
 5.3. Global Autoimmune Disease Diagnostics Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
 5.4. Autoimmune Disease Diagnostics Market, Sub Segment Analysis
 5.4.1. Localized Autoimmune Disease Diagnostic
 5.4.2. Systemic Autoimmune Disease Diagnostic
 5.4.3.  
 Chapter 6. Global Autoimmune Disease Diagnostics Market, by Product 
 6.1. Market Snapshot 
 6.2. Global Autoimmune Disease Diagnostics Market by Product, Performance - Potential Analysis
 6.3. Global Autoimmune Disease Diagnostics Market Estimates & Forecasts by Product, 2016-2026 (USD Billion)
 6.4. Autoimmune Disease Diagnostics Market, Sub Segment Analysis
 6.4.1. Drugs 
 6.4.2. Therapeutic & Monitoring Equipment
 6.4.3. Diagnostic Equipment
 
 Chapter 7. Global Autoimmune Disease Diagnostics Market, by Technology 
 7.1. Market Snapshot 
 7.2. Global Autoimmune Disease Diagnostics Market by Technology, Performance - Potential Analysis
 7.3. Global Autoimmune Disease Diagnostics Market Estimates & Forecasts by Technology, 2016-2026 (USD Billion)
 7.4. Autoimmune Disease Diagnostics Market, Sub Segment Analysis
 7.4.1. Bridge Therapy
 7.4.2. Disease-Modifying Antirheumatic Drugs (DMARD)
 7.4.3. Topical Therapy
 7.4.4. Phototherapy
 7.4.5. Helminthic Therapy
 7.4.6. Recombinant Technology
 Chapter 8. Global Autoimmune Disease Diagnostics Market, Regional Analysis
 8.1. Autoimmune Disease Diagnostics Market, Regional Market Snapshot 
 8.2. North America Autoimmune Disease Diagnostics Market 
 8.2.1. U.S. Autoimmune Disease Diagnostics Market
 8.2.1.1. Type breakdown estimates & forecasts, 2016-2026 
 8.2.1.2. Product breakdown estimates & forecasts, 2016-2026 
 8.2.1.3. Technology breakdown estimates & forecasts, 2016-2026
 8.2.2. Canada Autoimmune Disease Diagnostics Market
 8.3. Europe Autoimmune Disease Diagnostics Market Snapshot
 8.3.1. U.K. Autoimmune Disease Diagnostics Market 
 8.3.2. Germany Autoimmune Disease Diagnostics Market
 8.3.3. Rest of Europe Autoimmune Disease Diagnostics Market
 8.4. Asia-Pacific Autoimmune Disease Diagnostics Market Snapshot
 8.4.1. China Autoimmune Disease Diagnostics Market 
 8.4.2. India Autoimmune Disease Diagnostics Market 
 8.4.3. Japan Autoimmune Disease Diagnostics Market
 8.4.4. Rest of Asia Pacific Autoimmune Disease Diagnostics Market
 8.5. Latin America Autoimmune Disease Diagnostics Market Snapshot
 8.5.1. Brazil Autoimmune Disease Diagnostics Market
 8.5.2. Mexico Autoimmune Disease Diagnostics Market
 8.6. Rest of The World Autoimmune Disease Diagnostics Market
 
 Chapter 9. Competitive Intelligence
 9.1. Top Market Strategies
 9.2. Company Profiles
 9.2.1. Thermo Fisher Scientific
 9.2.1.1. Key Information
 9.2.1.2. Overview
 9.2.1.3. Financial (Subject to Data Availability)
 9.2.1.4. Product Summary
 9.2.1.5. Recent Developments
 9.2.2. Siemens Healthineers
 9.2.3. Abbott Laboratories
 9.2.4. Danaher Corporation
 9.2.5. Bio-Rad Laboratories, Inc.
 9.2.6. Grifols
 9.2.7. Trinity Biotech
 9.2.8. Werfen
 9.2.9. HYCOR Biomedical
 9.2.10. Exagen Inc.
 Chapter 10. Research Process
 10.1. Research Process
 10.1.1. Data Mining
 10.1.2. Analysis
 10.1.3. Market Estimation
 10.1.4. Validation
 10.1.5. Publishing
 10.2. Research Attributes
 10.3. Research Assumption

Global Autoimmune Disease Diagnostics Market is valued approximately USD 3.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 9.20% over the forecast period 2019-2026. The Autoimmune diseases refer to body’s abnormal immune response resulting in the production of antibodies that impact or attack own cells & tissues which leads to destruction and deterioration of healthy tissues. In the present scenario, there are around 80 types of autoimmune diseases such as systematic lupus erythematosus and rheumatoid arthritis prevalent in the global scenario. The Autoimmune disease diagnostics market is primarily driven owing to a high prevalence of autoimmune diseases, escalating awareness, about autoimmune diseases, rise in the number of growth activities on autoimmune diseases and escalating utility of biosensors for autoimmune disease diagnostics. The high incidence and prevalence of autoimmune diseases is acting as a key factor in the development and growth of autoimmune disease diagnostics market. For instance: according to the American Autoimmune Related Diseases Association (AARDA), the autoimmune disease impacts around 50 million individuals residing in both urban and semi-urban provinces among which 75% are females in the United States resulting in fueling the demand and adoption of autoimmune disease diagnostics market. However, high capital requirements impede the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Autoimmune Disease Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high incidence & prevalence of autoimmune diseases and growth in number of research activities on autoimmune diseases. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as rising aging population along with use of biosensors for autoimmune disease diagnosis would create lucrative growth prospects for the Autoimmune Disease Diagnostics market across Asia-Pacific region.

Major market player included in this report are:
Thermo Fisher Scientific
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
Bio-Rad Laboratories, Inc.
Grifols
Trinity Biotech
Werfen
HYCOR Biomedical
Exagen Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Localized Autoimmune Disease Diagnostic
Systemic Autoimmune Disease Diagnostic
By Product:
Drugs
Therapeutic & Monitoring Equipment
Diagnostic Equipment
By Technology:
Bridge Therapy
Disease-Modifying Antirheumatic Drugs (DMARD)
Topical Therapy
Phototherapy
Helminthic Therapy
Recombinant Technology
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 20198
Forecast period – 2020 to 2026

Target Audience of the Global Autoimmune Disease Diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…